Norwich Pharmacal Co v Customs and Excise Comrs

Last updated

Norwich Pharmacal Co. v Customs and Excise
Royal Coat of Arms of the United Kingdom.svg
Court House of Lords
Full case nameNorwich Pharmacal Co. & Ors v Commissioners of Customs and Excise
Decided26 June 1973
Citation(s)[1973] 3 WLR 164; [1973] FSR 365; [1973] 2 All ER 943; [1974] RPC 101; [1973] UKHL 6; [1974] AC 133
Transcript(s) Full text of judgment
Court membership
Judge(s) sitting Lord Reid
Lord Morris of Borth-y-Gest
Viscount Dilhorne
Lord Cross of Chelsea
Lord Kilbrandon
Keywords
interim injunctions; pre-action disclosure; application notice; quia timet injunctions; joint tortfeasors; freezing orders; search orders; cause of action; preliminary injunctions; locus standi

Norwich Pharmacal Co. & Others v Customs and Excise Commissioners [1974] AC 133 was a case involving the owner and exclusive licensee of a patent, which was infringed by unknown importers of the chemical into the United Kingdom. Norwich Pharmacal Co brought proceedings against the Excise Commissioners to force the disclosure of information which would identify the importer of the chemical, and therefore those who infringed the patent. The House of Lords held that where a third party had information relating to unlawful conduct, a court could compel them to assist the person suffering damage by giving them that information. The case established the Norwich Pharmacal jurisdiction and disclosure orders against third parties are now known as Norwich Pharmacal orders in the UK.

Contents

The case

The case was brought by Norwich Pharmacal Co. and the exclusive licensee of a patent for an antibacterial called furazolidone. Between 1960 and 1970 unlicensed shipments of the chemical were imported into Britain, therefore Norwich Pharmacal Co. knew that its patent was infringed but was unable to identify the importers. The Commissioners for Customs & Excise held information that would identify the importers, but would not disclose this, claiming that they had no authority to give such information. [1] Norwich Pharmacal Co. brought proceedings against the Excise Commissioners, to force the Commissioners to disclose the names of the importers, which were the Intended Defendants. In Norwich Pharmacal Co. v Customs and Excise Commissioners [1974] the House of Lords held that where a third party has information relating to unlawful conduct, a court could compel them to assist the person suffering damage by giving them that information. [1] The judgement is based on the 19th Century procedure known as the bill of discovery. [2] Lord Reid summarised what became known as the Norwich Pharmacal jurisdiction as follows:

...that if through no fault of his own a person gets mixed up in the tortious acts of others so as to facilitate their wrongdoing he may incur no personal liability but he comes under a duty to assist the person who has been wronged by giving him full information and disclosing the identity of the wrongdoers. [2]

Norwich Pharmacal jurisdiction

The 1974 House of Lords ruling in Norwich Pharmacal Co. v Customs and Excise Commissioners established what is known as the Norwich Pharmacal jurisdiction, which allows UK courts to grant disclosure orders, known as Norwich Pharmacal orders, against third parties which have been mixed up in wrongdoing. By identifying individuals the documents and information sought are disclosed in order to assist the applicant for such an order in bringing legal proceedings against individuals who are believed to have wronged the applicant. While first developed in relation to intellectual property, such as patents, Norwich Pharmacal orders are now granted in relation to other torts, as well as defamation and breach of contract, and alleged criminal offences. More recently Norwich Pharmacal orders are used against internet hosting services and internet service providers to identify users which have allegedly engaged in wrongdoing. [3]

See also

Related Research Articles

<span class="mw-page-title-main">Trade secret</span> Business information kept secret to gain or maintain a competitive advantage

Trade secrets are a type of intellectual property that includes formulas, practices, processes, designs, instruments, patterns, or compilations of information that have inherent economic value because they are not generally known or readily ascertainable by others, and which the owner takes reasonable measures to keep secret. Intellectual property law gives the owner of a trade secret the right to restrict others from disclosing it.

Public-interest immunity (PII), previously known as Crown privilege, is a principle of English common law under which the English courts can grant a court order allowing one litigant to refrain from disclosing evidence to the other litigants where disclosure would be damaging to the public interest. This is an exception to the usual rule that all parties in litigation must disclose any evidence that is relevant to the proceedings. In making a PII order, the court has to balance the public interest in the administration of justice and the public interest in maintaining the confidentiality of certain documents whose disclosure would be damaging. PII orders have been used in criminal law against large organised criminal outfits and drug dealers where the identity of paid police informants could be at risk.

Prior art is a concept in patent law used to determine the patentability of an invention, in particular whether an invention meets the novelty and the inventive step or non-obviousness criteria for patentability. In most systems of patent law, prior art is generally defined as anything that is made available, or disclosed, to the public that might be relevant to a patent's claim before the effective filing date of a patent application for an invention. However, notable differences exist in how prior art is specifically defined under different national, regional, and international patent systems.

<span class="mw-page-title-main">Patent infringement</span> Breach of the rights conferred by a patent

Patent infringement is the commission of a prohibited act with respect to a patented invention without permission from the patent holder. Permission may typically be granted in the form of a license. The definition of patent infringement may vary by jurisdiction, but it typically includes using or selling the patented invention. In many countries, a use is required to be commercial to constitute patent infringement.

The United States is considered to have the most favorable legal regime for inventors and patent owners in the world. Under United States law, a patent is a right granted to the inventor of a (1) process, machine, article of manufacture, or composition of matter, (2) that is new, useful, and non-obvious. A patent is the right to exclude others, for a limited time from profiting from a patented technology without the consent of the patent holder. Specifically, it is the right to exclude others from: making, using, selling, offering for sale, importing, inducing others to infringe, applying for an FDA approval, and/or offering a product specially adapted for practice of the patent.

Japanese patent law is based on the first-to-file principle and is mainly given force by the Patent Act of Japan. Article 2 defines an invention as "the highly advanced creation of technical ideas utilizing the law of nature".

This is a list of legal terms relating to patents and patent law. A patent is not a right to practice or use the invention claimed therein, but a territorial right to exclude others from commercially exploiting the invention, granted to an inventor or their successor in rights in exchange to a public disclosure of the invention.

Asset freezing is a form of interim or interlocutory injunction which prevents a defendant to an action from dealing with or dissipating its assets so as to frustrate a potential judgment. It is widely recognised in other common law jurisdictions and such orders can be made to have world-wide effect. It is variously construed as part of a court's inherent jurisdiction to restrain breaches of its process.

<span class="mw-page-title-main">Canadian patent law</span>

Canadian patent law is the legal system regulating the granting of patents for inventions within Canada, and the enforcement of these rights in Canada.

<span class="mw-page-title-main">Isle of Man Treasury</span>

The Treasury of the Isle of Man is the finance department of the Isle of Man Government. It prepares the annual budget for the Government, and also handles taxation, customs and excise, economic affairs, information systems, internal audit, currency and the census in the Isle of Man.

<span class="mw-page-title-main">Trademark</span> Trade identifier of products or services

A trademark is a type of intellectual property consisting of a recognizable sign, design, or expression that identifies a product or service from a particular source and distinguishes it from others. A trademark owner can be an individual, business organization, or any legal entity. A trademark may be located on a package, a label, a voucher, or on the product itself. Trademarks used to identify services are sometimes called service marks.

The Public Servants Disclosure Protection Act came into force in Canada on April 15, 2007. The Act creates two distinct processes: a disclosure process and a reprisal complaints process. It also creates two new bodies: the Office of the Public Sector Integrity Commissioner (PSIC) and the Public Servants Disclosure Protection Tribunal.

In India, a customs house agent (CHA) is licensed to act as an agent for transaction of any business relating to the entry or departure of conveyances or the import or export of goods at a customs station. CHAs maintain detailed, itemized and up-to-date accounts. A CHA license may be temporary or permanent.

A Norwich Pharmacal order is a court order for the disclosure of documents or information that is available in the United Kingdom and Ireland. It is granted against a third party which has been mixed up in wrongdoing, forcing the disclosure of documents or information. By identifying individuals the documents and information sought are disclosed in order to assist the applicant for such an order in bringing legal proceedings against individuals who are believed to have wronged the applicant.

The Customs, Excise and Service Tax Appellate Tribunal (CESTAT) is an Indian quasi-judicial body that hears appeals against orders and decisions passed under the Customs Act, 1962 and Central Excise Act, 1944 as amended from time to time. It was constituted as Customs, Excise and Gold (Control) Appellate Tribunal (CEGAT) under section 129 of Customs Act, 1962, as amended by section 50 and the Fifth Schedule of Finance Act, 1980. These amendments became effective from 11 October 1982 and the Tribunal was also constituted on the same date. Its initial mandate was under Customs Act, 1962, Central Excise Act, 1944 and Gold (Control) Act, 1968. Service tax was introduced by Chapter V of Finance Act, 1994 and this also was added to the jurisdiction of CEGAT. Accordingly, the name of the Tribunal was changed to Customs, Excise and Service Tax Appellate Tribunal (CESTAT) by amending section 129 of the Customs Act, by section 119 of Finance Act, 2003, effective from 14 May 2003.

<span class="mw-page-title-main">Remedies in Singapore administrative law</span> Types of legal orders applicable on Singapore Governments executive branch

The remedies available in Singapore administrative law are the prerogative orders – the mandatory order, prohibiting order (prohibition), quashing order (certiorari), and order for review of detention – and the declaration, a form of equitable remedy. In Singapore, administrative law is the branch of law that enables a person to challenge an exercise of power by the executive branch of the Government. The challenge is carried out by applying to the High Court for judicial review. The Court's power to review a law or an official act of a government official is part of its supervisory jurisdiction, and at its fullest may involve quashing an action or decision and ordering that it be redone or remade.

<span class="mw-page-title-main">Defences and remedies in Canadian patent law</span>

A patent holder in Canada has the exclusive right, privilege and liberty to making, constructing, using and selling the invention for the term of the patent, from the time the patent is granted. Any person who does any of these acts in relation to an invention without permission of the patent owner is liable for patent infringement.

Under French law, the saisie-contrefaçon is a means of proof of the infringement and, more generally, any violation of an intellectual property right. This procedure permits the holder of the intellectual property right, upon receiving the authorisation of a judge, to call upon a bailiff to record an infringement. In France, the saisie-contrefaçon is one of the most widely used means of obtaining evidence of the existence and extent of an infringement of intellectual property rights.

<span class="mw-page-title-main">Outline of patents</span> Overview of and topical guide to patents

The following outline is provided as an overview of and topical guide to patents:

<span class="mw-page-title-main">Design infringement</span> Breach of intellectual property rights

Design is a form of intellectual property right concerned with the visual appearance of articles which have commercial or industrial use. The visual form of the product is what is protected rather than the product itself. The visual features protected are the shape, configuration, pattern or ornamentation. A design infringement is where a person infringes a registered design during the period of registration. The definition of a design infringement differs in each jurisdiction but typically encompasses the purported use and make of the design, as well as if the design is imported or sold during registration. To understand if a person has infringed the monopoly of the registered design, the design is assessed under each jurisdiction's provisions. The infringement is of the visual appearance of the manufactured product rather than the function of the product, which is covered under patents. Often infringement decisions are more focused on the similarities between the two designs, rather than the differences.

References

  1. 1 2 "Norwich Pharmacal Orders". Gillhams LLP. Retrieved 30 September 2010.
  2. 1 2 Sime, Stuart (2007). A Practical Approach to Civil Procedure. Oxford University Press. p. 381. ISBN   9780199212330.
  3. Smith, Graham (2007). Internet Law and regulation (4th ed.). Sweet & Maxwell. p. 441. ISBN   9780421909908.